Compare GHC & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GHC | TMDX |
|---|---|---|
| Founded | 1877 | 1998 |
| Country | United States | United States |
| Employees | 19920 | N/A |
| Industry | Other Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.6B |
| IPO Year | 1994 | 2019 |
| Metric | GHC | TMDX |
|---|---|---|
| Price | $1,073.64 | $102.13 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $154.00 |
| AVG Volume (30 Days) | 15.2K | ★ 990.7K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | ★ 66.47 | 4.87 |
| Revenue | ★ $2,932,099,000.00 | $605,494,000.00 |
| Revenue This Year | $10.54 | $24.51 |
| Revenue Next Year | $4.02 | $18.73 |
| P/E Ratio | ★ $16.11 | $21.57 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $875.60 | $62.42 |
| 52 Week High | $1,224.76 | $156.00 |
| Indicator | GHC | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 50.16 | 25.93 |
| Support Level | $1,020.89 | $99.95 |
| Resistance Level | $1,115.27 | $131.86 |
| Average True Range (ATR) | 25.27 | 6.00 |
| MACD | 3.91 | -2.63 |
| Stochastic Oscillator | 69.58 | 0.24 |
Graham Holdings Company is a diversified holding company with operations spanning educational services, television broadcasting, healthcare, manufacturing, automotive dealerships, and other businesses. The Company's education activities are conducted through Kaplan, whose services include academic preparation programs for international students, English-language programs, exam preparation, and career and academic advisement. These services are provided to students, schools, and colleges, both domestically and outside the United States. It operates through seven reportable segments: Kaplan International, Kaplan Higher Education, Kaplan Supplemental Education, Television Broadcasting, CSI, Manufacturing and Automotive, with key revenue coming from the Education and Automotive segments.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.